Arkolith/Insider Trading/TPST/Form 4

Dubensky Thomas W.

President, DirectorMillendo Therapeutics, Inc. (TPST) · full profile →Form 4 · filed Jun 29, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 25, 2021Grant(A)111K——111K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 25, 2021Grant(A)46K——46K
Jun 25, 2021Grant(A)1.0M——1.0M
Jun 25, 2021Grant(A)8K——8K
Jun 25, 2021Grant(A)36K——36K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-21-022784) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Millendo Therapeutics, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp